Jove
Visualize
Contact Us

Related Experiment Videos

Differential antigen processing by dendritic cell subsets in vivo.

Diana Dudziak1, Alice O Kamphorst, Gordon F Heidkamp

  • 1Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10021, USA.

Science (New York, N.Y.)
|January 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD32b defines distinct dendritic cell lineages generated from the culture of bone marrow with GM-CSF.

Frontiers in immunology·2026
Same author

Therapeutic effect of T-cell engager in two patients with autoimmune neuropathy.

Nature communications·2026
Same author

FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

Journal for immunotherapy of cancer·2026
Same author

TRP53/p53 protects adult hippocampal neural stem cells from psychological stress by preventing autophagic cell death.

Autophagy·2026
Same author

Protocol for mapping murine myeloid bone marrow progenitors and their differentiation into CD103<sup>+</sup> cDC1s and CD301b<sup>+</sup> cDC2s.

STAR protocols·2026
Same author

FAP-Targeted LTBR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumours.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dendritic cells (DCs) present antigens differently based on their type. CD8- DCs specialize in presenting antigens via MHC class II, unlike CD8+ DCs, due to intrinsic processing differences.

Area of Science:

  • Immunology
  • Cell Biology
  • Antigen Presentation

Background:

  • Dendritic cells (DCs) are crucial for immune responses, processing and presenting antigens to induce tolerance or immunity.
  • While in vitro studies suggest antigen presentation regulates immunity, in vivo mechanisms controlled by DCs remain largely unknown.

Purpose of the Study:

  • To investigate how dendritic cells (DCs) control antigen processing and presentation in vivo.
  • To differentiate the in vivo functions of major DC subsets.

Main Methods:

  • Targeted delivery of antigens to specific DC subsets using chimeric monoclonal antibodies.
  • Analysis of antigen processing and presentation pathways in vivo.

Main Results:

Related Experiment Videos

  • Two major DC subsets, CD8+ and CD8- DCs, exhibit distinct antigen presentation capabilities in vivo.
  • CD8- DCs (33D1+) are specialized for presentation on Major Histocompatibility Complex (MHC) class II.
  • CD8+ DCs (CD205+) differ in their antigen presentation pathways compared to CD8- DCs.
  • Intrinsic differences in antigen processing, including increased expression of MHC processing proteins, define DC subset specialization.
  • Conclusions:

    • Dendritic cell subsets possess distinct, intrinsic mechanisms for antigen processing and presentation in vivo.
    • This subset specialization plays a critical role in determining immune outcomes, such as tolerance or immunity.